Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes

被引:75
作者
Maekinen, Ville-Petteri [1 ,2 ,3 ]
Forsblom, Carol [2 ,3 ]
Thorn, Lena M. [2 ,3 ]
Waden, Johan [2 ,3 ]
Gordin, Daniel [2 ,3 ]
Heikkilae, Outi [2 ,3 ]
Hietala, Kustaa [2 ,3 ]
Kylloenen, Laura [2 ,3 ]
Kytoe, Janne [2 ,3 ]
Rosengard-Baerlund, Milla [2 ,3 ]
Saraheimo, Markku [2 ,3 ]
Tolonen, Nina [2 ,3 ]
Parkkonen, Maija [2 ,3 ]
Kaski, Kimmo [1 ]
Ala-Korpela, Mika [1 ,2 ,3 ]
Groop, Per-Henrik [2 ,3 ]
机构
[1] Aalto Univ, Dept Biomed Engn & Computat Sci, Helsinki, Finland
[2] Biomed Helsinki, Folkhalsan Inst Genet, Folkhalsan Res Ctr, Helsinki, Finland
[3] Helsinki Univ Hosp, Dept Med, Div Nephrol, Helsinki, Finland
基金
芬兰科学院;
关键词
D O I
10.2337/db08-0332
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIEVE-Poor glycemic control, elevated triglycerides, and albuminuria are associated with vascular complications in diabetes. However, few studies have investigated combined associations between metabolic markers, diabetic kidney disease, retinopathy, hypertension, obesity, and mortality. Here, the goal was to reveal previously undetected association patterns between clinical diagnoses and biochemistry in the FinnDiane dataset. RESEARCH DESIGN AND METHODS-At baseline, clinical records, serum, and 24-h urine samples of 2,173 men and 2,024 women with type 1 diabetes were collected. The data were analyzed by the self-organizing map, which is an unsupervised pattern recognition algorithm that produces a two-dimensional layout of the patients based on their multivariate biochemical profiles. At follow-up, the results were compared against all-cause mortality during 6.5 years (295 deaths). RESULTS-The highest mortality was associated with advanced kidney disease. Other risk factors included 1) a profile of insulin resistance, abdominal obesity, high cholesterol, triglycerides, and low HDL2 cholesterol, and 2) high adiponectin and high LDL cholesterol for older patients. The highest population-adjusted risk of death was 10.1-fold (95% CI 7.3-13.1) for men and 10.7-fold (7.9-13.7) for women. Nonsignificant risk was observed for a profile with good glycemic control and high HDL, cholesterol and for a low cholesterol profile with a short diabetes duration. CONCLUSIONS-The self-organizing map analysis enabled detailed risk estimates, described the associations between known risk factors and complications, and uncovered statistical patterns difficult to detect by classical methods. The results also suggest that diabetes per se, without an adverse metabolic phenotype, does not contribute to increased mortality.
引用
收藏
页码:2480 / 2487
页数:8
相关论文
共 50 条
[1]   Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy [J].
Al-Kateb, Hussam ;
Boright, Andrew P. ;
Mirea, Lucia ;
Xie, Xinlei ;
Sutradhar, Rinku ;
Mowjoodi, Afireza ;
Bharaj, Bhupinder ;
Liu, Michelle ;
Bucksa, Jean M. ;
Arends, Valerie L. ;
Steffes, Michael W. ;
Cleary, Patricia A. ;
Sun, Wanjie ;
Lachin, John M. ;
Thorner, Paul S. ;
Ho, Michael ;
McKnight, Amy Jayne ;
Maxwell, A. Peter ;
Savage, David A. ;
Kidd, Kenneth K. ;
Kidd, Judith R. ;
Speed, William C. ;
Trevor, J. Orchard ;
Miller, Rachel G. ;
Sun, Lei ;
Bull, Shelley B. ;
Paterson, Andrew D. .
DIABETES, 2008, 57 (01) :218-228
[2]   Characterization and molecular detection of atherothrombosis by magnetic resonance-potential tools for individual risk assessment and diagnostics [J].
Ala-Korpela, Mika ;
Sipola, Petri ;
Kaski, Kimmo .
ANNALS OF MEDICINE, 2006, 38 (05) :322-336
[3]   Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes [J].
Boright, AP ;
Paterson, AD ;
Mirea, L ;
Bull, SB ;
Mowjoodi, A ;
Scherer, SW ;
Zinman, B .
DIABETES, 2005, 54 (04) :1238-1244
[4]   The need for early predictors of diabetic nephropathy risk - Is albumin excretion rate sufficient? [J].
Caramori, ML ;
Fioretto, P ;
Mauer, M .
DIABETES, 2000, 49 (09) :1399-1408
[5]   Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes [J].
Chaturvedi, N ;
Fuller, JH ;
Taskinen, MR .
DIABETES CARE, 2001, 24 (12) :2071-2077
[6]   Risk factors for renal failure: The WHO multinational study of vascular disease in diabetes [J].
Colhoun, HM ;
Lee, ET ;
Bennett, PH ;
Lu, M ;
Keen, H ;
Wang, SL ;
Stevens, LK ;
Fuller, JH .
DIABETOLOGIA, 2001, 44 (Suppl 2) :S46-S53
[7]   Validation of the Framingham Coronary Heart Disease prediction scores - Results of a multiple ethnic groups investigation [J].
D'Agostino, RB ;
Grundy, S ;
Sullivan, LM ;
Wilson, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02) :180-187
[8]   The metabolic syndrome [J].
Eckel, RH ;
Grundy, SM ;
Zimmet, PZ .
LANCET, 2005, 365 (9468) :1415-1428
[9]   Incidence of end-stage renal disease in patients with type 1 diabetes [J].
Finne, P ;
Reunanen, A ;
Stenman, S ;
Groop, PH ;
Grönhagen-Riska, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (14) :1782-1787
[10]   Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications [J].
Frystyk, J ;
Tarnow, L ;
Hansen, TK ;
Parving, HH ;
Flyvbjerg, A .
DIABETOLOGIA, 2005, 48 (09) :1911-1918